51(top 2%)
papers
1.9K(top 1%)
citations
24(top 1%)
h-index
44(top 1%)
g-index
51
all documents
1.9K
doc citations
636
citing journals

Top Articles

#TitleJournalYearCitations
1Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular ImmunotherapyHuman Gene Therapy1999177
2Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord bloodBlood1994164
3Treatment of cancer-associated thrombosisBlood2013158
4Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis2018140
5Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experienceBone Marrow Transplantation1998101
6Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid LeukemiaBlood199791
7A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from bloodBiology of Blood and Marrow Transplantation199684
8Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3British Journal of Haematology199374
9Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokinesBlood199371
10Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokinesBlood199367
11Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte GlobulinJournal of Hematotherapy and Stem Cell Research200060
12Hodgkin's Lymphoma in AdolescentsJournal of Clinical Oncology200655
13Multicolor fluorescence in situ hybridization with peptide nucleic acid probes for enumeration of specific chromosomes in human cellsGenes Chromosomes and Cancer200152
14High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantationBone Marrow Transplantation199850
15Shifting to outpatient management of acute myeloid leukemia: a prospective experienceAnnals of Oncology200647
16Long-Term Outcome of Myeloablative Allogeneic Stem Cell Transplantation for Multiple MyelomaBiology of Blood and Marrow Transplantation200744
17Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphomaAnnals of Oncology201441
18Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord bloodBlood199435
19Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350 cGy) and Fludarabine ConditioningBiology of Blood and Marrow Transplantation201132
20Stress, social rank and leukocyte telomere lengthAging Cell200629
21Azathioprine‐associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S‐methyltransferase deficiencyAmerican Journal of Hematology200829
22Gas-chromatographic analysis of busulfan for therapeutic drug monitoringCancer Chemotherapy and Pharmacology199328
23Patient Experience of Living With Cancer‐Associated Thrombosis in Canada (PELICANADA)Research and Practice in Thrombosis and Haemostasis202026
24Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trialsLeukemia and Lymphoma201224
25Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsBiology of Blood and Marrow Transplantation201524
26Immunotherapy after bone marrow transplantationBone Marrow Transplantation199124
27IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell TransplantationBiology of Blood and Marrow Transplantation200923
28Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple MyelomaOncologist201323
29Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokinesBlood199321
30COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional studyThrombosis Journal201820
31Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalitiesBritish Journal of Haematology199815
32The Role of Erythropoietin and Other Growth Factors in Transfusion MedicineTransfusion Medicine Reviews199113
33Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)Thrombosis and Haemostasis202112
34Paraneoplastic Erythropoietin-Induced Polycythemia Associated With Small Lymphocytic LymphomaJournal of Clinical Oncology200611
35Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trialBritish Journal of Haematology202110
36Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO studyThrombosis Research202110
37Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid LeukemiaBlood199710
38Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotypeLeukemia20109
39Spontaneous remission of multilobated non-Hodgkin lymphomaAmerican Journal of Hematology19927
40Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophiliaLeukemia and Lymphoma20137
41Direct Oral Anticoagulants in Cancer PatientsSeminars in Thrombosis and Hemostasis20197
42Interleukin-6 does not support interleukin-2 induced generation of human lymphokine-activated killer cellsCancer Immunology, Immunotherapy19915
43RETURN TO DURABLE DONOR HAEMATOPOIESIS AFTER BLAST PHASE RELAPSE OF CHRONIC MYELOID LEUKAEMIA FOLLOWING MARROW TRANSPLANTATIONBritish Journal of Haematology19924
44Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord bloodBlood19943
45Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian populationScientific Reports20213
46Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor eraLeukemia Research20182
47Successful Allogeneic Hematopoietic Cell Transplantation Using Flu-Bu-ATG Conditioning for “Mono-MAC Syndrome” [GATA2 Deficiency]Biology of Blood and Marrow Transplantation20161
48Updates from the 2017 American Society of Hematology Annual Meeting: Practice-Changing Studies in Untreated Chronic Lymphocytic LeukemiaCurrent Oncology20180
49Long Term Follow-Up Results for Patients with Hodgkin Lymphoma after First Remission of Longer Than Ten Years: A Population Based Study of 954 Patients from the British Columbia Cancer Agency.Blood20060
50Incidence and Outcomes of Catheter Related Thrombosis in Acute Leukemia: Single Centre ExperienceBlood20160